核性白内障的临床试验
总计1982个结果
-
Radboud University Medical CenterThe Netherlands Cancer Institute; Isala招聘中
-
Radboud University Medical CenterDutch Cancer Society完全的
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd完全的肾细胞癌 | 透明细胞转移性肾细胞癌美国, 加拿大
-
SCRI Development Innovations, LLCNovartis完全的
-
Tianjin Medical University Cancer Institute and...未知
-
University of California, San DiegoThe Cleveland Clinic未知
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)撤销
-
Radboud University Medical CenterDutch Cancer Society完全的
-
National Cancer Institute (NCI)NRG Oncology主动,不招人
-
Spanish Oncology Genito-Urinary GroupPfizer; Apices Soluciones S.L.完全的
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University终止
-
Queen Mary University of London未知
-
University Hospital, MontpellierCentre Hospitalier Universitaire de Besancon招聘中
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.完全的
-
Ajjai Alva, MDAstraZeneca; Big Ten Cancer Research Consortium主动,不招人
-
Telix International Pty Ltd完全的
-
Association Pour La Recherche des Thérapeutiques...完全的
-
Central European Society for Anticancer Drug Research完全的
-
Arkadiusz Z. Dudek, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research Consortium完全的
-
Hoosier Cancer Research NetworkBionomics Limited完全的
-
Bristol-Myers SquibbOno Pharma USA Inc完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb完全的
-
Instituto do Cancer do Estado de São PauloPfizer未知
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...终止
-
Tianjin Medical University Second Hospital尚未招聘
-
AIO-Studien-gGmbHBristol-Myers Squibb完全的癌,肾细胞 | 透明细胞转移性肾细胞癌西班牙, 法国, 意大利, 德国, 英国, 比利时, 捷克语, 奥地利
-
Cliniques universitaires Saint-Luc- Université...终止
-
Sunnybrook Health Sciences CentrePfizer完全的Clear Cell, Metastatic Renal Cell Carcinoma加拿大
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., Auckland未知
-
KU LeuvenGlaxoSmithKline; Novartis; Pfizer; Flemish League Against Cancer完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢透明细胞囊腺癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢浆液性囊腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 原发性腹膜浆液性腺癌 | 卵巢粘液性囊腺癌 | 未分化卵巢癌 | IIIC 期输卵管癌 | IIIC 期卵巢癌 | IIIC 期原发性腹膜癌 | IV 期输卵管癌 | IV 期卵巢癌 | IV 期原发性腹膜癌 | 输卵管子宫内膜样瘤 | 未分化输卵管癌 | 输卵管粘液性肿瘤 | 输卵管浆液性肿瘤美国
-
University of WashingtonNational Cancer Institute (NCI)终止卵巢癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢未分化癌 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 输卵管腺癌 | 输卵管移行细胞癌 | 卵巢腺癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 输卵管未分化癌 | 恶性卵巢布伦纳瘤 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | 输卵管癌肉瘤 | 卵巢癌肉瘤 | 原发性腹膜癌肉瘤 | 原发性腹膜移行细胞癌美国